Clinical trials recruiting for BRAF Gene Mutation
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Binimetinib | 1 |
| Cetuximab | 1 |
| Dabrafenib | 1 |
| Encorafenib | 1 |
| FOLFIRI | 1 |
| FOLFOX6/FOLFOX7 | 1 |
| Gemcitabine | 1 |
| Nab-paclitaxel | 1 |
| Nilotinib 100mg | 1 |
| Nilotinib 200mg | 1 |
| Nilotinib 300mg | 1 |
| Nilotinib 400mg | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Tennessee | 2 |
| Arizona | 1 |
| California | 1 |
| Colorado | 1 |
| Connecticut | 1 |
| District of Columbia | 1 |
| Iowa | 1 |
| Kentucky | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
| Minnesota | 1 |
| Missouri | 1 |
Top cities
Self-screener
Recruiting trials
- Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Colorectal Cancer
- Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma
- Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Related conditions
Trials recruiting for BRAF Gene Mutation often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for BRAF Gene Mutation trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.